Document:

Exhibit 4.1

      

       

      LDH Growth Corp I

      

        DESCRIPTION OF SECURITIES

       

      The following summary of the material terms of the securities of LDH Growth Corp I is not intended to be a complete summary of the rights and
        preferences of such securities and is subject to and qualified by reference to our amended and restated memorandum and articles of association incorporated by reference as an exhibit to the company’s Annual Report on Form 10-K for the year ended
        December 31, 2021, and applicable Cayman Islands law.  We urge you to read our amended and restated memorandum and articles of association in their entirety for a complete description of the rights and preferences our securities.

       

      Certain Terms

       

      Unless otherwise stated in this Annual Report on Form 10-K or the context otherwise requires, references to:

       

      	

            	•	
              “amended and restated memorandum and articles of association” are to the amended and restated memorandum and articles of association that the company adopted in connection with our initial public offering;

            

       

      	

            	•	
              “Companies Act” are to the Companies Act (as amended) of the Cayman Islands as the same may be amended from time to time;

            

       

      	

            	•	
              “forward purchase agreement” are to the agreement providing for the sale of forward purchase units to the forward purchase investors in a private placement that will close substantially concurrently with the
                closing of our initial business combination;

            

       

      	

            	•	
              “forward purchase investor” are to (i) LDH Sponsor LLC;

            

       

      	

            	•	
              “forward purchase securities” are to the forward purchase shares and forward purchase warrants;

            

       

      	

            	•	
              “forward purchase shares” are to the Class A ordinary shares included in the forward purchase units;

            

       

      	

            	•	
              “forward purchase units” are to the units issued to the forward purchase investor pursuant to the forward purchase agreement;

            

       

      	

            	•	
              “forward purchase warrants” are to the warrants to purchase our Class A ordinary shares included in the forward purchase units;

            

       

      	

            	•	
              “founder shares” are to our Class B ordinary shares initially issued to our sponsor in a private placement before our initial public offering and the Class A ordinary shares that will be issued upon the automatic
                conversion of the Class B ordinary shares upon our initial business combination or earlier at the option of the holders thereof; provided that such Class A ordinary shares issued upon any conversion of Class B ordinary shares will not be
                treated as “public shares” for any purpose;

            

       

      	

            	•	
              “management” or our “management team” are to our executive officers and directors;

            

       

      	

            	•	
              “ordinary resolution” means a resolution of the company adopted by the affirmative vote of at least a majority of the votes cast by the holders of the issued shares present in person or represented by proxy at a
                general meeting of the company and entitled to vote on such matter, or a resolution approved in writing by all of the holders of the issued shares entitled to vote on such matter;

            

       

      
        
          

      

      
      	

            	•	
              “ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares;

            

       

      	

            	•	
              “private placement warrants” are to the warrants to be issued to our sponsor in a private placement simultaneously with our initial public offering’s closing and upon conversion of working capital loans, if any;

            

       

      	

            	•	
              “public shares” are to our Class A ordinary shares sold as part of the units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market), but the
                term “public shares” specifically excludes all of our Class A ordinary shares that are issued upon conversion of our Class B ordinary shares;

            

       

      	

            	•	
              “public shareholders” are to the holders of our public shares, including our sponsor and management team to the extent that our sponsor and/or our management-team members buy public shares; and provided that our
                sponsor and/or management-team members will have the status of “public shareholder(s)” with respect to such public shares only;

            

       

      	

            	•	
              “warrants” are to our redeemable warrants sold as part of the units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market, including warrants
                that may be acquired by our sponsor or its affiliates in our initial public offering or thereafter in the open market);

            

       

      	

            	•	
              “SoftBank Latin America Fund” are to SoftBank Latin America Fund L.P., an Ontario limited partnership;

            

       

      	

            	•	
              “SoftBank” are to SoftBank Group Corp., an affiliate of our sponsor;

            

       

      	

            	•	
              “special resolution” means a resolution of the company adopted by the affirmative vote of at least a two-thirds (2/3) majority (or such higher threshold as specified in the company’s amended and restated
                memorandum and articles of association) of the votes cast by the holders of the issued shares present in person or represented by proxy at a general meeting of the company and entitled to vote on such matter, or a resolution approved in
                writing by all of the holders of the issued shares entitled to vote on such matter;

            

       

      	

            	•	
              “sponsor” are to LDH Sponsor LLC, a Delaware limited liability company; and

            

       

      	

            	•	
              “we,” “us,” “our,” “company,” or “our company” means LDH Growth Corp I, a Cayman Islands exempted company.

            

       

       We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Act and the
        common law of the Cayman Islands.  Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 200,000,000 Class A ordinary shares, 20,000,000 Class B ordinary shares, and 1,000,000 preference shares,
        each with a nominal or par value of $0.0001.  The following description summarizes the material terms of our shares as set out more particularly in our amended and restated memorandum and articles of association.  Because it is only a summary, it
        may not contain all the information that is important to you.

       

      Units

       

      Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-fifth of one redeemable warrant.  Each whole warrant
        entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described in the final prospectus related to our initial public offering.  Pursuant to the warrant agreement, a warrant
        holder may exercise its warrants only for a whole number of the company’s Class A ordinary shares.  This means only a whole warrant may be exercised at any given time by a warrant holder.

       

      
        2

        
          

      

      The Class A ordinary shares and warrants comprising the units began separate trading on The Nasdaq Capital Market on May 10, 2021.

       

      Additionally, the units will automatically separate into their component parts and will not be traded after completion of our initial business
        combination.

       

      Ordinary Shares

       

      As of December 31, 2021, there were 23,000,000 Class A ordinary shares issued and outstanding and 5,750,000 Class B ordinary shares issued and
        outstanding.

       

      Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders.  Except as described below,
        holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders except as required by law.  Unless specified in our amended and restated
        memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of our ordinary shares that are voted is required to approve any such matter
        voted on by our shareholders.  Approval of certain actions will require a special resolution under the Companies Act and our amended and restated memorandum and articles of association; such actions include amending our amended and restated
        memorandum and articles of association and approving a statutory merger or consolidation with another company.  Our board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class
        of directors being appointed in each year.  There is no cumulative voting with respect to the appointment of directors, with the result that the holders of more than 50% of the shares voted for the appointment of directors can appoint all of the
        directors.  Our shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.  Prior to our initial business combination, only holders of our founder shares will
        have the right to vote on the appointment of directors.  Holders of our public shares will not be entitled to vote on the appointment of directors during such time.  In addition, prior to the completion of an initial business combination, holders
        of a majority of our founder shares may remove a member of the board of directors for any reason.  In addition, in a vote to continue the company in a jurisdiction outside the Cayman Islands (including any ancillary votes or approvals required in
        connection with any such continuation to another jurisdiction including, but not limited to, the approval of the organizational documents of the company in such other jurisdiction), which requires the approval of at least two thirds of the votes of
        all ordinary shares, holders of our Class B ordinary shares will have ten votes for every Class B ordinary share and holders of our Class A ordinary shares will have one vote for every Class A ordinary share.  The provisions of our amended and
        restated memorandum and articles of association governing the appointment or removal of directors prior to our initial business combination and our continuation in a jurisdiction outside the Cayman Islands prior to our initial business combination
        may only be amended by a special resolution, which shall include the affirmative vote of a simple majority of our Class B ordinary shares.

       

      Because our amended and restated memorandum and articles of association authorizes the issuance of up to 200,000,000 Class A ordinary shares, if we
        were to enter into a business combination, we may (depending on the terms of such a business combination) be required to increase the number of Class A ordinary shares which we will be authorized to issue at the same time as our shareholders vote
        on the business combination to the extent we seek shareholder approval in connection with our initial business combination.

       

      Our board of directors is divided into three classes with only one class of directors being appointed in each year and each class (except for those
        directors appointed prior to our first annual general meeting) serving a three-year term.  In accordance with corporate governance requirements of The Nasdaq Capital Market (“NASDAQ”), we are not required to hold an annual general meeting until one
        year after our first fiscal year end following our listing on NASDAQ.  There is no requirement under the Companies Act for us to hold annual or general meetings to appoint directors.  We may not hold an annual general meeting to appoint new
        directors prior to the consummation of our initial business combination.  Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder
        shares.  In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason.

       

      
        3

        
          

      

      Our public shareholders will have the opportunity to redeem all or a portion of their public shares upon the completion of our initial business
        combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on the
        funds held in the trust account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein.  The amount in the trust account is
        approximately $10.00 per public share.  The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters.  The redemption rights will
        include the requirement that a beneficial owner must identify itself in order to validly redeem its shares.  Our sponsor, our independent directors, and each member of our management team have entered into an agreement with us, pursuant to which
        they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination, and (ii) a shareholder vote to approve an amendment to
        our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial
        business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or during any Extension Period (as defined in the prospectus for our
        initial public offering) or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares.  Unlike many blank check companies that hold shareholder votes and conduct proxy solicitations in conjunction with
        their initial business combinations and provide for related redemptions of public shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required by applicable law
        or stock exchange listing requirements, if a shareholder vote is not required by applicable law or stock exchange listing requirements and we do not decide to hold a shareholder vote for business or other reasons, we will, pursuant to our amended
        and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing our initial business combination.  Our amended and restated
        memorandum and articles of association require these tender offer documents to contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under the SEC’s proxy
        rules.  If, however, a shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or we decide to obtain shareholder approval for business or other reasons, we will, like many blank check
        companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules.  If we seek shareholder approval, we will complete our initial business combination only if we obtain
        the approval of an ordinary resolution.  However, the participation of our sponsor, officers, directors, advisors or their affiliates in privately-negotiated transactions (as described in the final prospectus related to our initial public
        offering), if any, could result in the approval of our initial business combination even if a majority of our public shareholders vote, or indicate their intention to vote, against such initial business combination.  For purposes of seeking
        approval of the majority of our issued and outstanding ordinary shares, non-votes will have no effect on the approval of our initial business combination once a quorum is obtained.  Our amended and restated memorandum and articles of association
        require that at least five days’ notice will be given of any general meeting.

       

      If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
        combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is
        acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in our initial public offering, which we refer
        to as the “Excess Shares,” without our prior consent.  However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination.  Our shareholders’
        inability to redeem the Excess Shares will reduce their influence over our ability to complete our initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares on the open
        market.  Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination.  And, as a result, such shareholders will continue to hold that number of shares
        exceeding 15% and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.

       

      
        4

        
          

      

      If we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution.  In such
        case, our sponsor and each member of our management team have agreed to vote their founder shares and public shares in favor of our initial business combination.  Additionally, each public shareholder may elect to redeem their public shares
        irrespective of whether they vote for or against the proposed transaction or vote at all.

       

      Pursuant to our amended and restated memorandum and articles of association, if we have not consummated an initial business combination within 24
        months from the closing of our initial public offering or during any Extension Period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter,
        redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our
        income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the
        right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject
        in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.  Our sponsor, our independent directors and each member of our management team have
        entered into an agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination
        within 24 months from the closing of our initial public offering or during any Extension Period (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete
        our initial business combination within the prescribed time frame).  Our amended and restated memorandum and articles of association provides that, if a resolution of the company’s shareholders is passed pursuant to the Companies Act of the Cayman
        Islands to commence the voluntary liquidation of the company, we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject to
        applicable Cayman Islands law.

       

      In the event of a liquidation or winding up and dissolution of the company after a business combination, our shareholders are entitled to share ratably
        in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the ordinary shares.  Our shareholders have no preemptive or other
        subscription rights.  There are no sinking fund provisions applicable to the ordinary shares, except that we will provide our public shareholders with the opportunity to redeem their public shares for cash at a per share price equal to the
        aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares,
        upon the completion of our initial business combination, subject to the limitations described herein.

       

      Founder Shares

       

      The founder shares are designated as Class B ordinary shares and, except as described below, are identical to the Class A ordinary shares included in
        the units, and holders of founder shares have the same shareholder rights as public shareholders, except that:  (a) prior to our initial business combination, only holders of the founder shares have the right to vote on the appointment of directors
        and holders of a majority of our founder shares may remove a member of the board of directors for any reason; (b) the founder shares are subject to certain transfer restrictions, as described in more detail below; (c) in a vote to continue the
        company in a jurisdiction outside the Cayman Islands (including any ancillary votes or approvals required in connection with any such continuation to another jurisdiction including, but not limited to, the approval of the organizational documents
        of the company in such other jurisdiction), which requires the approval of at least two thirds of the votes of all ordinary shares, holders of our founder shares will have ten votes for every founder share and holders of our Class A ordinary shares
        will have one vote for every Class A ordinary share; (d) our sponsor and each member of our management team have entered into an agreement with us, pursuant to which they have agreed to (i) waive their redemption rights with respect to their
        founder shares (ii) to waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (A) that
        would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not
        complete our initial business combination within 24 months from the closing of our initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares;
        and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if we fail to consummate an initial business combination within 24 months from the closing of our initial public offering
        or during any Extension Period (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed time
        frame); (e) the founder shares will automatically convert into our Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described herein; and (f) the founder shares are entitled
        to registration rights.  If we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution.  In such case, our sponsor and each member of our management team have agreed to
        vote their founder shares and public shares in favor of our initial business combination.

       

      
        5

        
          

      

      The founder shares are designated as Class B ordinary shares and will automatically convert into Class A ordinary shares (which such Class A ordinary
        shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the trust account if we do not consummate an initial business combination) at the time of our initial business combination or earlier
        at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of
        ordinary shares issued and outstanding upon completion of our initial public offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights
        issued or deemed issued, by the company in connection with or in relation to the consummation of the initial business combination, excluding any forward purchase securities and Class A ordinary shares or equity-linked securities exercisable for or
        convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to our sponsor, its affiliates or any member of our management team upon
        conversion of working capital loans.  In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

       

      Except as described herein, our sponsor and our directors and executive officers have agreed not to transfer, assign or sell any of their founder
        shares until earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares
        equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial
        business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or
        other property.  We refer to such transfer restrictions throughout this exhibit as the lock-up.  Any permitted transferees would be subject to the same restrictions and other agreements of our sponsor and our directors and executive officers with
        respect to any founder shares.

       

      Prior to our initial business combination, only holders of our founder shares will have the right to vote on the appointment of directors.  Holders of
        our public shares will not be entitled to vote on the appointment of directors during such time.  In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board
        of directors for any reason.  In addition, in a vote to continue the company in a jurisdiction outside the Cayman Islands (including any ancillary votes or approvals required in connection with any such continuation to another jurisdiction
        including, but not limited to, the approval of the organizational documents of the company in such other jurisdiction), which requires the approval of at least two thirds of the votes of all ordinary shares, holders of our founder shares will have
        ten votes for every founder share and holders of our Class A ordinary shares will have one vote for every Class A ordinary share and, as a result, our initial shareholders will be able to approve any such proposal without the vote of any other
        shareholder. These provisions of our amended and restated memorandum and articles of association may only be amended by a special resolution, which shall include the affirmative vote of a simple majority of our Class B ordinary shares.  With
        respect to any other matter submitted to a vote of our shareholders, including any vote in connection with our initial business combination, except as required by law, holders of our founder shares and holders of our public shares will vote
        together as a single class, with each share entitling the holder to one vote.

       

      
        6

        
          

      

      Preference Shares

       

      Our amended and restated memorandum and articles of association authorizes 1,000,000 preference shares and provide that preference shares may be issued
        from time to time in one or more series.  Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations
        and restrictions thereof, applicable to the shares of each series.  Our board of directors is able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights
        of the holders of the ordinary shares and could have anti-takeover effects.  The ability of our board of directors to issue preference shares without shareholder approval could have the effect of delaying, deferring or preventing a change of
        control of us or the removal of existing management.  We have no preference shares issued and outstanding at the date hereof.  Although we do not currently intend to issue any preference shares, we cannot assure you that we will not do so in the
        future.

       

      Warrants

       

      Public Shareholders’ Warrants

       

      Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as
        discussed below, at any time commencing on the later of one year from the closing of our initial public offering and 30 days after the completion of our initial business combination, except as discussed in the immediately succeeding paragraph. 
        Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class A ordinary shares.  This means only a whole warrant may be exercised at a given time by a warrant holder.  No fractional warrants were
        issued upon separation of the units and only whole warrants are traded.  Accordingly, a holder must have at least five units  to receive or trade a whole warrant.  The warrants will expire five years after the completion of our initial business
        combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

       

      We are not obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant
        exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations
        described below with respect to registration, or a valid exemption from registration is available.  No warrant will be exercisable and we will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary
        share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.  In the event that the conditions in the two immediately
        preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless.  In no event will we be required to net cash settle
        any warrant.  In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share
        underlying such unit.

       

      We have agreed that as soon as practicable, but in no event later than twenty business days after the closing of our initial business combination, we
        will use our commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and we will use our commercially
        reasonable efforts to cause the same to become effective within 60 business days after the closing of our initial business combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those
        Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if our Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such
        that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require holders of warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9)
        of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky
        laws to the extent an exemption is not available.  If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial business combination,
        warrant holders may, until such time as there is an effective registration statement and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section
        3(a)(9) of the Securities Act or another exemption, but we will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.  In such event, each holder would
        pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied
        by the excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361 per warrant.  The “fair market value” as used in this paragraph shall mean the volume weighted average price
        of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.

       

      
        7

        
          

      

      Redemption of warrants when the price per Class A
          ordinary share equals or exceeds $18.00.  Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement
          warrants and forward purchase warrants):

       

      • in whole and not in part;

       

      • at a price of $0.01 per warrant;

       

      • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

       

      • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon
        exercise or the exercise price of a warrant as described under the heading “—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) on the trading day prior to the date on which we send the notice of redemption to the warrant holders.

       

      We will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A
        ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period.  If and when the warrants become redeemable by us, we
        may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.

       

      We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a
        significant premium to the warrant exercise price.  If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled
        redemption date.  Any such exercise would not be done on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.  However, the price of the Class A ordinary shares may fall
        below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants—Public Shareholders’ Warrants—Anti-dilution
        Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

       

      Redemption of warrants when the price per Class A
          ordinary share equals or exceeds $10.00.  Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants
          and forward purchase warrants):

       

      • in whole and not in part;

       

      • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders
        will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of our Class A ordinary shares
        (as defined below) except as otherwise described below; and

       

      • if, and only if, the closing price of our Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares
        issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) on the trading day prior to the date on which we send the notice of redemption to the
        warrant holders.

       

      
        8

        
          

      

      Beginning on the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect to exercise their warrants on a
        cashless basis.  The numbers in the table below represent the number of Class A ordinary shares that a warrant holder will receive upon such cashless exercise in connection with a redemption by us pursuant to this redemption feature, based on the
        “fair market value” of our Class A ordinary shares on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on volume
        weighted average price of our Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date
        precedes the expiration date of the warrants, each as set forth in the table below.  We will provide our warrant holders with the final fair market value no later than one business day after the 10-trading day period described above ends.

       

      Pursuant to the warrant agreement, references above to Class A ordinary shares shall include a security other than Class A ordinary shares into which
        the Class A ordinary shares have been converted or exchanged for in the event we are not the surviving company in our initial business combination.  The numbers in the table below will not be adjusted when determining the number of Class A ordinary
        shares to be issued upon exercise of the warrants if we are not the surviving entity following our initial business combination.

       

      The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon
        exercise of a warrant or the exercise price of a warrant is adjusted as set forth under the heading “— Anti-dilution Adjustments” below.  If the number of shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the
        column headings will equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the exercise price of the warrant after such adjustment and the denominator of which is the price of the warrant
        immediately prior to such adjustment.  In such an event, the number of shares in the table below shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable upon exercise of a
        warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted.  If the exercise price of a warrant is adjusted, (a) in the case of an adjustment pursuant to
        the fifth paragraph under the heading “—Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the numerator of which is the higher of the Market Value and
        the Newly Issued Price as set forth under the heading “ — Anti-dilution Adjustments” and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to the second paragraph under the heading “— Anti-dilution Adjustments” below,
        the adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the exercise price of a warrant pursuant to such exercise price adjustment.

       

      

      
        9

        
          

      

      
        	
                Redemption Date

              	
                ​

              	
                ​

              	
                Fair Market Value of Class A Ordinary Shares

              
	
                (period to expiration of warrants)

              	
                ​

              	
                ​

              	
                <10.00

              	
                ​

              	
                ​

              	
                11.00

              	
                ​

              	
                ​

              	
                12.00

              	
                ​

              	
                ​

              	
                13.00

              	
                ​

              	
                ​

              	
                14.00

              	
                ​

              	
                ​

              	
                15.00

              	
                ​

              	
                ​

              	
                16.00

              	
                ​

              	
                ​

              	
                17.00

              	
                ​

              	
                ​

              	
                >18.00

              
	
                60 months

              	
                ​

              	
                ​

              	
                0.261

              	
                ​

              	
                ​

              	
                0.281

              	
                ​

              	
                ​

              	
                0.297

              	
                ​

              	
                ​

              	
                0.311

              	
                ​

              	
                ​

              	
                0.324

              	
                ​

              	
                ​

              	
                0.337

              	
                ​

              	
                ​

              	
                0.348

              	
                ​

              	
                ​

              	
                0.358

              	
                ​

              	
                ​

              	
                0.361

              
	
                57 months

              	
                ​

              	
                ​

              	
                0.257

              	
                ​

              	
                ​

              	
                0.277

              	
                ​

              	
                ​

              	
                0.294

              	
                ​

              	
                ​

              	
                0.310

              	
                ​

              	
                ​

              	
                0.324

              	
                ​

              	
                ​

              	
                0.337

              	
                ​

              	
                ​

              	
                0.348

              	
                ​

              	
                ​

              	
                0.358

              	
                ​

              	
                ​

              	
                0.361

              
	
                54 months

              	
                ​

              	
                ​

              	
                0.252

              	
                ​

              	
                ​

              	
                0.272

              	
                ​

              	
                ​

              	
                0.291

              	
                ​

              	
                ​

              	
                0.307

              	
                ​

              	
                ​

              	
                0.322

              	
                ​

              	
                ​

              	
                0.335

              	
                ​

              	
                ​

              	
                0.347

              	
                ​

              	
                ​

              	
                0.357

              	
                ​

              	
                ​

              	
                0.361

              
	
                51 months

              	
                ​

              	
                ​

              	
                0.246

              	
                ​

              	
                ​

              	
                0.268

              	
                ​

              	
                ​

              	
                0.287

              	
                ​

              	
                ​

              	
                0.304

              	
                ​

              	
                ​

              	
                0.320

              	
                ​

              	
                ​

              	
                0.333

              	
                ​

              	
                ​

              	
                0.346

              	
                ​

              	
                ​

              	
                0.357

              	
                ​

              	
                ​

              	
                0.361

              
	
                48 months

              	
                ​

              	
                ​

              	
                0.241

              	
                ​

              	
                ​

              	
                0.263

              	
                ​

              	
                ​

              	
                0.283

              	
                ​

              	
                ​

              	
                0.301

              	
                ​

              	
                ​

              	
                0.317

              	
                ​

              	
                ​

              	
                0.332

              	
                ​

              	
                ​

              	
                0.344

              	
                ​

              	
                ​

              	
                0.356

              	
                ​

              	
                ​

              	
                0.361

              
	
                45 months

              	
                ​

              	
                ​

              	
                0.235

              	
                ​

              	
                ​

              	
                0.258

              	
                ​

              	
                ​

              	
                0.279

              	
                ​

              	
                ​

              	
                0.298

              	
                ​

              	
                ​

              	
                0.315

              	
                ​

              	
                ​

              	
                0.330

              	
                ​

              	
                ​

              	
                0.343

              	
                ​

              	
                ​

              	
                0.356

              	
                ​

              	
                ​

              	
                0.361

              
	
                42 months

              	
                ​

              	
                ​

              	
                0.228

              	
                ​

              	
                ​

              	
                0.252

              	
                ​

              	
                ​

              	
                0.274

              	
                ​

              	
                ​

              	
                0.294

              	
                ​

              	
                ​

              	
                0.312

              	
                ​

              	
                ​

              	
                0.328

              	
                ​

              	
                ​

              	
                0.342

              	
                ​

              	
                ​

              	
                0.355

              	
                ​

              	
                ​

              	
                0.361

              
	
                39 months

              	
                ​

              	
                ​

              	
                0.221

              	
                ​

              	
                ​

              	
                0.246

              	
                ​

              	
                ​

              	
                0.269

              	
                ​

              	
                ​

              	
                0.290

              	
                ​

              	
                ​

              	
                0.309

              	
                ​

              	
                ​

              	
                0.325

              	
                ​

              	
                ​

              	
                0.340

              	
                ​

              	
                ​

              	
                0.354

              	
                ​

              	
                ​

              	
                0.361

              
	
                36 months

              	
                ​

              	
                ​

              	
                0.213

              	
                ​

              	
                ​

              	
                0.239

              	
                ​

              	
                ​

              	
                0.263

              	
                ​

              	
                ​

              	
                0.285

              	
                ​

              	
                ​

              	
                0.305

              	
                ​

              	
                ​

              	
                0.323

              	
                ​

              	
                ​

              	
                0.339

              	
                ​

              	
                ​

              	
                0.353

              	
                ​

              	
                ​

              	
                0.361

              
	
                33 months

              	
                ​

              	
                ​

              	
                0.205

              	
                ​

              	
                ​

              	
                0.232

              	
                ​

              	
                ​

              	
                0.257

              	
                ​

              	
                ​

              	
                0.280

              	
                ​

              	
                ​

              	
                0.301

              	
                ​

              	
                ​

              	
                0.320

              	
                ​

              	
                ​

              	
                0.337

              	
                ​

              	
                ​

              	
                0.352

              	
                ​

              	
                ​

              	
                0.361

              
	
                30 months

              	
                ​

              	
                ​

              	
                0.196

              	
                ​

              	
                ​

              	
                0.224

              	
                ​

              	
                ​

              	
                0.250

              	
                ​

              	
                ​

              	
                0.274

              	
                ​

              	
                ​

              	
                0.297

              	
                ​

              	
                ​

              	
                0.316

              	
                ​

              	
                ​

              	
                0.335

              	
                ​

              	
                ​

              	
                0.351

              	
                ​

              	
                ​

              	
                0.361

              
	
                27 months

              	
                ​

              	
                ​

              	
                0.185

              	
                ​

              	
                ​

              	
                0.214

              	
                ​

              	
                ​

              	
                0.242

              	
                ​

              	
                ​

              	
                0.268

              	
                ​

              	
                ​

              	
                0.291

              	
                ​

              	
                ​

              	
                0.313

              	
                ​

              	
                ​

              	
                0.332

              	
                ​

              	
                ​

              	
                0.350

              	
                ​

              	
                ​

              	
                0.361

              
	
                24 months

              	
                ​

              	
                ​

              	
                0.173

              	
                ​

              	
                ​

              	
                0.204

              	
                ​

              	
                ​

              	
                0.233

              	
                ​

              	
                ​

              	
                0.260

              	
                ​

              	
                ​

              	
                0.285

              	
                ​

              	
                ​

              	
                0.308

              	
                ​

              	
                ​

              	
                0.329

              	
                ​

              	
                ​

              	
                0.348

              	
                ​

              	
                ​

              	
                0.361

              
	
                21 months

              	
                ​

              	
                ​

              	
                0.161

              	
                ​

              	
                ​

              	
                0.193

              	
                ​

              	
                ​

              	
                0.223

              	
                ​

              	
                ​

              	
                0.252

              	
                ​

              	
                ​

              	
                0.279

              	
                ​

              	
                ​

              	
                0.304

              	
                ​

              	
                ​

              	
                0.326

              	
                ​

              	
                ​

              	
                0.347

              	
                ​

              	
                ​

              	
                0.361

              
	
                18 months

              	
                ​

              	
                ​

              	
                0.146

              	
                ​

              	
                ​

              	
                0.179

              	
                ​

              	
                ​

              	
                0.211

              	
                ​

              	
                ​

              	
                0.242

              	
                ​

              	
                ​

              	
                0.271

              	
                ​

              	
                ​

              	
                0.298

              	
                ​

              	
                ​

              	
                0.322

              	
                ​

              	
                ​

              	
                0.345

              	
                ​

              	
                ​

              	
                0.361

              
	
                15 months

              	
                ​

              	
                ​

              	
                0.130

              	
                ​

              	
                ​

              	
                0.164

              	
                ​

              	
                ​

              	
                0.197

              	
                ​

              	
                ​

              	
                0.230

              	
                ​

              	
                ​

              	
                0.262

              	
                ​

              	
                ​

              	
                0.291

              	
                ​

              	
                ​

              	
                0.317

              	
                ​

              	
                ​

              	
                0.342

              	
                ​

              	
                ​

              	
                0.361

              
	
                12 months

              	
                ​

              	
                ​

              	
                0.111

              	
                ​

              	
                ​

              	
                0.146

              	
                ​

              	
                ​

              	
                0.181

              	
                ​

              	
                ​

              	
                0.216

              	
                ​

              	
                ​

              	
                0.250

              	
                ​

              	
                ​

              	
                0.282

              	
                ​

              	
                ​

              	
                0.312

              	
                ​

              	
                ​

              	
                0.339

              	
                ​

              	
                ​

              	
                0.361

              
	
                9 months

              	
                ​

              	
                ​

              	
                0.090

              	
                ​

              	
                ​

              	
                0.125

              	
                ​

              	
                ​

              	
                0.162

              	
                ​

              	
                ​

              	
                0.199

              	
                ​

              	
                ​

              	
                0.237

              	
                ​

              	
                ​

              	
                0.272

              	
                ​

              	
                ​

              	
                0.305

              	
                ​

              	
                ​

              	
                0.336

              	
                ​

              	
                ​

              	
                0.361

              
	
                6 months

              	
                ​

              	
                ​

              	
                0.065

              	
                ​

              	
                ​

              	
                0.099

              	
                ​

              	
                ​

              	
                0.137

              	
                ​

              	
                ​

              	
                0.178

              	
                ​

              	
                ​

              	
                0.219

              	
                ​

              	
                ​

              	
                0.259

              	
                ​

              	
                ​

              	
                0.296

              	
                ​

              	
                ​

              	
                0.331

              	
                ​

              	
                ​

              	
                0.361

              
	
                3 months

              	
                ​

              	
                ​

              	
                0.034

              	
                ​

              	
                ​

              	
                0.065

              	
                ​

              	
                ​

              	
                0.104

              	
                ​

              	
                ​

              	
                0.150

              	
                ​

              	
                ​

              	
                0.197

              	
                ​

              	
                ​

              	
                0.243

              	
                ​

              	
                ​

              	
                0.286

              	
                ​

              	
                ​

              	
                0.326

              	
                ​

              	
                ​

              	
                0.361

              
	
                0 months

              	
                ​

              	
                ​

              	
                —

              	
                ​

              	
                ​

              	
                —

              	
                ​

              	
                ​

              	
                0.042

              	
                ​

              	
                ​

              	
                0.115

              	
                ​

              	
                ​

              	
                0.179

              	
                ​

              	
                ​

              	
                0.233

              	
                ​

              	
                ​

              	
                0.281

              	
                ​

              	
                ​

              	
                0.323

              	
                ​

              	
                ​

              	
                0.361

              

      

      

      The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values
        in the table or the redemption date is between two redemption dates in the table, the number of Class A ordinary shares to be issued for each warrant exercised will be determined by a straight-line interpolation between the number of shares set
        forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable.  For example, if the volume weighted average price of our Class A ordinary shares for the 10
        trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders may
        choose to, in connection with this redemption feature, exercise their warrants for 0.277 Class A ordinary shares for each whole warrant.  For an example where the exact fair market value and redemption date are not as set forth in the table above,
        if the volume weighted average price of our Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such
        time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 Class A ordinary shares for each whole warrant.  In no event will the warrants be
        exercisable on a cashless basis in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).  Finally, as reflected in the table above, if the warrants are out of the money and about to
        expire, they cannot be exercised on a cashless basis in connection with a redemption by us pursuant to this redemption feature, since they will not be exercisable for any Class A ordinary shares.

       

      
        10

        
          

      

      This redemption feature differs from the typical warrant redemption features used in many other blank check offerings, which typically only provide for
        a redemption of warrants for cash (other than the private placement warrants) when the trading price for the Class A ordinary shares exceeds $18.00 per share for a specified period of time.  This redemption feature is structured to allow for all of
        the outstanding warrants to be redeemed when the Class A ordinary shares are trading at or above $10.00 per public share, which may be at a time when the trading price of our Class A ordinary shares is below the exercise price of the warrants.  We
        have established this redemption feature to provide us with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under “—Redemption of warrants when the price per Class A
        ordinary share equals or exceeds $18.00.” Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a
        fixed volatility input as of the date of the final prospectus related to our initial public offering.  This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty
        as to our capital structure as the warrants would no longer be outstanding and would have been exercised or redeemed.  We will be required to pay the applicable redemption price to warrant holders if we choose to exercise this redemption right and
        it will allow us to quickly proceed with a redemption of the warrants if we determine it is in our best interest to do so.  As such, we would redeem the warrants in this manner when we believe it is in our best interest to update our capital
        structure to remove the warrants and pay the redemption price to the warrant holders.

       

      As stated above, we can redeem the warrants when the Class A ordinary shares are trading at a price starting at $10.00, which is below the exercise
        price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares.  If
        we choose to redeem the warrants when the Class A ordinary shares are trading at a price below the exercise price of the warrants, this could result in the warrant holders receiving fewer Class A ordinary shares than they would have received if
        they had chosen to wait to exercise their warrants for Class A ordinary shares if and when such Class A ordinary shares were trading at a price higher than the exercise price of $11.50.

       

      No fractional Class A ordinary shares will be issued upon exercise.  If, upon exercise, a holder would be entitled to receive a fractional interest in
        a share, we will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder.  If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant
        to the warrant agreement (for instance, if we are not the surviving company in our initial business combination), the warrants may be exercised for such security.  At such time as the warrants become exercisable for a security other than the Class
        A ordinary shares, the company (or surviving company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

       

      Redemption procedures.

       

      A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to
        exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a
        holder may specify) of the Class A ordinary shares issued and outstanding immediately after giving effect to such exercise.

       

      
        11

        
          

      

      Anti-dilution Adjustments.  If the number of outstanding Class A ordinary shares is increased by a capitalization or share dividend payable in Class A ordinary shares, or by a subdivision of ordinary shares or other similar event,
          then, on the effective date of such capitalization or share dividend, subdivision or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding
          ordinary shares.  A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the “historical fair market value” (as defined below) will be deemed a
          share dividend of a number of Class A ordinary shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are
          convertible into or exercisable for Class A ordinary shares) and (ii) one minus the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the historical fair market value.  For these purposes, (i) if the rights
          offering is for securities convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any
          additional amount payable upon exercise or conversion and (ii) “historical fair market value” means the volume weighted average price of Class A ordinary shares as reported during the 10 trading day period ending on the trading day prior to the
          first date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

       

      In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other
        assets to all or substantially all of the holders of the Class A ordinary shares on account of such Class A ordinary shares (or other securities into which the warrants are convertible), other than (a) as described above, (b) any cash dividends or
        cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day period ending on the date of declaration of such dividend or distribution does
        not exceed $0.50 (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of Class A ordinary shares issuable on exercise of
        each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a
        proposed initial business combination, (d) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the
        substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our
        initial business combination within 24 months from the closing of our initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, or (e) in
        connection with the redemption of our public shares upon our failure to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of
        cash and/or the fair market value of any securities or other assets paid on each Class A ordinary share in respect of such event.

       

      If the number of outstanding Class A ordinary shares is decreased by a consolidation, combination, reverse share split or reclassification of Class A
        ordinary shares or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be
        decreased in proportion to such decrease in outstanding Class A ordinary shares.

       

      Whenever the number of Class A ordinary shares purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise
        price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Class A ordinary shares purchasable upon the exercise of the warrants immediately
        prior to such adjustment and (y) the denominator of which will be the number of Class A ordinary shares so purchasable immediately thereafter.

       

      In addition, if (x) we issue additional Class A ordinary shares or equity-linked securities,
          excluding the forward purchase securities, for capital raising purposes in connection with the closing of our initial business combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue
        price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates,
        as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business
        combination on the date of the consummation of our initial business combination (net of redemptions), and (z) the volume weighted average trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day
        prior to the day on which we consummate our initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the
        Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above under “—Redemption of warrants when the price per Class A ordinary share equals or
        exceeds $18.00” and “— Redemption of warrants when the price per Class A ordinary shares equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the
        $10.00 per share redemption trigger price described above under “— Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and
        the Newly Issued Price.

       

      
        12

        
          

      

      In case of any reclassification or reorganization of the issued and outstanding Class A ordinary shares (other than those described above or that
        solely affects the par value of such Class A ordinary shares), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not
        result in any reclassification or reorganization of our outstanding Class A ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an
        entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the Class A ordinary
        shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of Class A ordinary shares or other securities or property (including cash) receivable upon such reclassification,
        reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event.  However, if such
        holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant
        will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has
        been made to and accepted by such holders (other than a tender, exchange or redemption offer made by the company in connection with redemption rights held by shareholders of the company as provided for in the company’s amended and restated
        memorandum and articles of association or as a result of the redemption of Class A ordinary shares by the company if a proposed initial business combination is presented to the shareholders of the company for approval) under circumstances in which,
        upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of
        such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of
        the issued and outstanding Class A ordinary shares, the holder of a warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant
        holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to such tender or exchange offer, subject to
        adjustment (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the warrant agreement.  If less than 70% of the consideration receivable by the holders of Class A
        ordinary shares in such a transaction is payable in the form of Class A ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so
        listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced
        as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant.  The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an
        extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.  The purpose of such exercise price reduction is to provide
        additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.

       

      The warrants have been issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent,
        and us.  The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement
        to the description of the terms of the warrants and the warrant agreement set forth in the final prospectus related to our initial public offering , or defective provision (ii) amending the provisions relating to cash dividends on ordinary shares
        as contemplated by and in accordance with the warrant agreement or (iii) adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or
        desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants, provided that the approval by the holders of at least 50% of the then-outstanding warrants is required to make any change that
        adversely affects the interests of the registered holders.  You should review a copy of the warrant agreement, which will be filed as an exhibit to the registration statement of which the final prospectus related to our initial public offering is a
        part, for a complete description of the terms and conditions applicable to the warrants.

       

      
        13

        
          

      

      The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and
        receive Class A ordinary shares.  After the issuance of Class A ordinary shares upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.

       

      No fractional warrants were issued upon separation of the units and only whole warrants have traded.  If, upon exercise of the warrants, a holder would
        be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder.

       

      We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the warrant
        agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum
        for any such action, proceeding or claim.  See “Risk Factors- Our warrant agreement will designate the courts of the State of New York or the United States District Court for the Southern District of New York, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for
        disputes with our company.” This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive
        forum.

       

      Private Placement Warrants

       

      Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants.  The private placement
        warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination (except pursuant to
        limited exceptions to our officers and directors and other persons or entities affiliated with the initial purchasers of the private placement warrants) and are not redeemable by us so long as they are held by our sponsor or its permitted
        transferees.  Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.  If the private placement warrants are held by holders other than our sponsor or its permitted transferees, the
        private placement warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in our initial public offering.  Any amendment to the terms of the
        private placement warrants or any provision of the warrant agreement with respect to the private placement warrants will require a vote of holders of at least 50% of the number of the then outstanding private placement warrants.

       

      If holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or
        its warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “Sponsor fair market value”
        (defined below) over the exercise price of the warrants by (y) the Sponsor fair market value.  For these purposes, the “Sponsor fair market value” shall mean the average reported closing price of the Class A ordinary shares for the 10 trading days
        ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.  The reason that we have agreed that these warrants will be exercisable on a cashless basis so long as they are held by our
        sponsor and its permitted transferees is because it is not known at this time whether they will be affiliated with us following a business combination.  If they remain affiliated with us, their ability to sell our securities in the open market will
        be significantly limited.  We expect to have policies in place that restrict insiders from selling our securities except during specific periods of time.  Even during such periods of time when insiders will be permitted to sell our securities, an
        insider cannot trade in our securities if he or she is in possession of material non-public information.  Accordingly, unlike public shareholders who could exercise their warrants and sell the Class A ordinary shares received upon such exercise
        freely in the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities.  As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is
        appropriate.

       

      
        14

        
          

      

      In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or
        an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required.  Up to $1,500,000 of such loans may be convertible into warrants of the post business combination entity at a
        price of $1.50 per warrant at the option of the lender.  Such warrants would be identical to the private placement warrants.

       

      Forward Purchase Securities

       

      Prior to the completion of our initial public offering, we entered into a forward purchase agreement pursuant to which our sponsor that provided for
        the purchase of an aggregate of 5,000,000 forward purchase units consisting of one Class A ordinary share and one-fifth of one warrant to purchase one Class A ordinary share for $10.00 per unit, for an aggregate purchase price of $50.0 million at
        the election of the sponsor, in a private placement to close substantially concurrently with the closing of the initial business combination.  If the sale of the forward purchase units fails to close, for any reason, we may lack sufficient funds to
        consummate our initial business combination.  The terms of the forward purchase shares are generally identical to the Class A ordinary shares included in the units, except that they will have certain registration rights described below and be
        subject to certain transfer restrictions, as described herein.  The terms of the forward purchase warrants are generally identical to the private placement warrants, including for the purposes of redemption, as described herein.  The forward
        purchase agreement also provides that the forward purchase investor is entitled to registration rights with respect to (A) the forward purchase shares, (B) Class A ordinary shares issuable upon exercise of the forward purchase warrants and (C) any
        other Class A ordinary shares or warrants acquired by the forward purchase investor, including any acquired after we complete our initial business combination.

       

      Dividends

       

      We have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial
        business combination.  The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination.  The
        payment of any cash dividends subsequent to our initial business combination will be within the discretion of our board of directors at such time.  If we incur any indebtedness in connection with a business combination, our ability to declare
        dividends may be limited by restrictive covenants we may agree to in connection therewith.

       

      Our Transfer Agent and Warrant Agent

       

      The transfer agent for our ordinary shares and warrant agent for our warrants is Continental Stock Transfer & Trust Company.  We have agreed to
        indemnify Continental Stock Transfer & Trust Company in its roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and employees against all claims and losses that may arise out of acts performed
        or omitted for its activities in that capacity, except for any claims and losses due to any gross negligence or intentional misconduct of the indemnified person or entity.

       

      Listing of Securities

       

      Our publicly held units are listed on The Nasdaq Stock Market LLC under the symbol “LDHAU.”

       

      Certain Differences in Corporate Law

       

      Cayman Islands companies are governed by the Companies Act.  The Companies Act is modeled on English law but does not follow recent English law
        statutory enactments, and differs from laws applicable to United States corporations and their shareholders.  Set forth below is a summary of the material differences between the provisions of the Companies Act applicable to us and the laws
        applicable to companies incorporated in the United States and their shareholders.

       

      
        15

        
          

      

      Mergers and Similar Arrangements.  In certain circumstances, the Companies Act allows for mergers or consolidations between two Cayman Islands companies, or between a Cayman Islands exempted company and a company incorporated in another
          jurisdiction (provided that is facilitated by the laws of that other jurisdiction).

       

      Where the merger or consolidation is between two Cayman Islands companies, the directors of each company must approve a written plan of merger or
        consolidation containing certain prescribed information.  That plan or merger or consolidation must then be authorized by (a) a special resolution; and (b) such other authorization, if any, as may be specified in such constituent company’s articles
        of association.  No shareholder resolution is required for a merger between a parent company (i.e., a company that holds issued shares that together represent at least 90% of the votes at a general meeting of the subsidiary company) and its
        subsidiary company, if a copy of the plan of merger is given to every member of each subsidiary company to be merged unless that member agrees otherwise.  The consent of each holder of a fixed or floating security interest of a constituent company
        must be obtained, unless the court waives such requirement.  If the Cayman Islands Registrar of Companies is satisfied that the requirements of the Companies Act (which includes certain other formalities) have been complied with, the Registrar of
        Companies will register the plan of merger or consolidation.

       

      Where the merger or consolidation involves a foreign company, the procedure is similar, save that where the surviving or consolidated company is the
        Cayman Islands exempted company, the Cayman Islands Registrar of Companies is required to be satisfied in respect of any constituent overseas company that (i) the merger or consolidation is permitted or not prohibited by the constitutional
        documents of the foreign company and by the laws of the jurisdiction in which the foreign company is incorporated, and that those laws and any requirements of those constitutional documents have been or will be complied with; (ii) no petition or
        other similar proceeding has been filed and remains outstanding and no order made or resolution adopted to wind up or liquidate the foreign company in the jurisdiction in which the foreign company is existing; (iii) no receiver, trustee,
        administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the foreign company, its affairs or its property or any part thereof; (iv) no scheme, order, compromise or other similar arrangement has been
        entered into or made in any jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended or restricted; (v) the foreign company is able to pay its debts as they fall due and that the merger or consolidation
        is bona fide and not intended to defraud unsecured creditors of the foreign company; (vi) in respect of the transfer of any security interest granted by the foreign company to the surviving or consolidated company (a) consent or approval to the
        transfer has been obtained, released or waived; (b) the transfer is permitted by and has been approved in accordance with the constitutional documents of the foreign company; and (c) the laws of the jurisdiction of the foreign company with respect
        to the transfer have been or will be complied with; and (vii) the foreign company will, upon the merger or consolidation becoming effective, cease to be incorporated, registered or exist under the laws of the relevant foreign jurisdiction and
        (viii) there is no other reason why it would be against the public interest to permit the merger or consolidation.  The requirements set out in sections (i) to (vii) above shall be met by a director of the Cayman Islands exempted company making a
        declaration to the effect that, having made due enquiry, they are of the opinion that such requirements have been met, such declaration to include a statement of the assets and liabilities of the foreign company made up to the latest practicable
        date before making the declaration.

       

      Where the above procedures are adopted, the Companies Act provides for a right of dissenting shareholders to be paid a payment of the fair value of
        their shares upon their dissenting to the merger or consolidation if they follow a prescribed procedure.  In essence, that procedure is as follows:  (a) the shareholder must give his written objection to the merger or consolidation to the
        constituent company before the vote on the merger or consolidation, including a statement that the shareholder proposes to demand payment for their shares if the merger or consolidation is authorized by the vote; (b) within

        20 days following the date on which the merger or consolidation is approved by the shareholders, the constituent company must give written notice to each shareholder who made a written objection; (c) a shareholder must within 20 days following
        receipt of such notice from the constituent company, give the constituent company a written notice of his intention to dissent including, among other details, a demand for payment of the fair value of their shares; (d) within seven days following
        the date of the expiration of the period set out in paragraph (b) above or seven days following the date on which the plan of merger or consolidation is filed, whichever is later, the constituent company, the surviving company or the consolidated
        company must make a written offer to each dissenting shareholder to purchase their shares at a price that the company determines is the fair value and if the company and the shareholder agree the price within 30 days following the date on which the
        offer was made, the company must pay the shareholder such amount; and (e) if the company and the shareholder fail to agree a price within such 30 day period, within 20 days following the date on which such 30 day period expires, the company (and
        any dissenting shareholder) must file a petition with the Cayman Islands Grand Court to determine the fair value and such petition must be accompanied by a list of the names and addresses of the dissenting shareholders with whom agreements as to
        the fair value of their shares have not been reached by the company.  At the hearing of that petition, the court has the power to determine the fair value of the shares together with a fair rate of interest, if any, to be paid by the company upon
        the amount determined to be the fair value.  Any dissenting shareholder whose name appears on the list filed by the company may participate fully in all proceedings until the determination of fair value is reached.  These rights of a dissenting
        shareholder are not available in certain circumstances, for example, to dissenters holding shares of any class in respect of which an open market exists on a recognized stock exchange or recognized interdealer quotation system at the relevant date
        or where the consideration for such shares to be contributed are shares of any company listed on a national securities exchange or shares of the surviving or consolidated company.

       

      
        16

        
          

      

      Moreover, Cayman Islands law has separate statutory provisions that facilitate the reconstruction or amalgamation of companies in certain
        circumstances.  Schemes of arrangement will generally be more suited for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as a “scheme of arrangement” which may be tantamount to a
        merger.  In the event that a merger was sought pursuant to a scheme of arrangement (the procedures for which are more rigorous and take longer to complete than the procedures typically required to consummate a merger in the United States), the
        arrangement in question must be approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made and who must in addition represent three-fourths in value of each such class of shareholders or
        creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meeting summoned for that purpose.  The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand
        Court of the Cayman Islands.  While a dissenting shareholder would have the right to express to the court the view that the transaction should not be approved, the court can be expected to approve the arrangement if it satisfies itself that:

       

      	

            	•	
              the company is not proposing to act illegally or beyond the scope of its corporate authority and the statutory provisions as to dual majority vote have been complied with;

            

       

      	

            	•	
              the shareholders have been fairly represented at the meeting in question;

            

       

      	

            	•	
              the arrangement is such as a businessman would reasonably approve; and

            

       

      	

            	•	
              the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount to a “fraud on the minority.”

            

       

      If a scheme of arrangement or takeover offer (as described below) is approved, any dissenting shareholder would have no rights comparable to appraisal
        rights (providing rights to receive payment in cash for the judicially determined value of the shares), which would otherwise ordinarily be available to dissenting shareholders of United States corporations.

       

      Squeeze-out Provisions.  When a takeover offer is made and accepted by holders of 90% of the shares to whom the offer relates within four months, the offeror may, within a two-month period, require the holders of the remaining
          shares to transfer such shares on the terms of the offer.  An objection can be made to the Grand Court of the Cayman Islands, but this is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the
          shareholders.

       

      Further, transactions similar to a merger, reconstruction and/or an amalgamation may in some circumstances be achieved through means other than these
        statutory provisions, such as a share capital exchange, asset acquisition or control, or through contractual arrangements of an operating business.

       

      
        17

        
          

      

      Shareholders’ Suits.  Walkers, our Cayman Islands legal counsel, is not aware of any reported class action having been brought in a Cayman Islands court.

       

      Derivative actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions.  In
        most cases, we will be the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our officers or directors usually may not be brought by a shareholder.  However, based both on Cayman Islands
        authorities and on English authorities, which would in all likelihood be of persuasive authority and be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:

       

      	

            	•	
              a company is acting, or proposing to act, illegally or beyond the scope of its authority;

            

       

      	

            	•	
              the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of votes which have actually been obtained; or

            

       

      	

            	•	
              those who control the company are perpetrating a “fraud on the minority.”

            

       

      A shareholder may have a direct right of action against us where the individual rights of that shareholder have been infringed or are about to be
        infringed.

       

      Enforcement of Civil Liabilities.  The Cayman Islands has a different body of securities laws as compared to the United States and provides less protection to investors.  Additionally, Cayman Islands companies may not have standing to sue
          before the Federal courts of the United States.

       

      We have been advised by our Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us
        judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us
        predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature.  In those circumstances, although there is no statutory
        enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on
        the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met.  For a foreign judgment to be enforced in the Cayman
        Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud
        or obtained in a manner, and or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy).  A Cayman
        Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

       

      Special Considerations for Exempted Companies.  We are an exempted company with limited liability  under the Companies Act.  The Companies Act distinguishes between ordinary resident companies and exempted companies.  Any company that is registered in
          the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company.

        

       

        

      
        18

        
          

      

      Amended and Restated Memorandum and Articles of Association

       

      Our amended and restated memorandum and articles of association contain provisions designed to provide certain rights and protections that will apply
        to us until the completion of our initial business combination.  These provisions cannot be amended without a special resolution.  As a matter of Cayman Islands law, a resolution is deemed to be a special resolution where it has been approved by
        either (i) the affirmative vote of at least two-thirds (or any higher threshold specified in a company’s articles of association) of a company’s shareholders entitled to vote in person or, where proxies are allowed, by proxy at a general meeting
        for which notice specifying the intention to propose the resolution as a special resolution has been given; or (ii) if so authorized by a company’s articles of association, by a unanimous written resolution of all of the company’s shareholders. 
        Other than as described above, our amended and restated memorandum and articles of association provide that special resolutions must be approved either by at least two-thirds of the shares voted at a general meeting of the company (i.e., the lowest
        threshold permissible under Cayman Islands law), or by a unanimous written resolution of all of our shareholders.

       

      Our initial shareholders and their permitted transferees, if any, who collectively beneficially owned 20% of our ordinary shares upon the closing of
        our initial public, will participate in any vote to amend our amended and restated memorandum and articles of association and will have the discretion to vote in any manner they choose.  Specifically, our amended and restated memorandum and
        articles of association provide, among other things, that:

       

      • If we have not consummated an initial business combination within 24 months from the closing of our initial public offering or during any Extension Period, we will (i)
        cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on
        deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our income taxes that were paid by us or are payable by us, if any (less up to $100,000 of interest to pay
        dissolution expenses) divided by the number of the then- outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any);
        and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under
        Cayman Islands law to provide for claims of creditors and the requirements of other applicable law;

       

      
        

      
        1 Walkers comment: this was not included in the S-1 disclosures and can be removed if
            preferred.

         

          

      

      
        19

        
          

      

      • Prior to or in connection with our initial business combination, we may not issue additional securities that would entitle the holders thereof to (i) receive funds from
        the trust account or (ii) vote as a class with our public shares (a) on our initial business combination or on any other proposal presented to shareholders prior to or in connection with the completion of an initial business combination or (b) to
        approve an amendment to our amended and restated memorandum and articles of association to (x) extend the time we have to consummate a business combination beyond 24 months from the closing of our initial public offering or (y) amend the foregoing
        provisions;

       

      • Although we do not intend to enter into a business combination with a target business that is affiliated with our sponsor, our directors or our officers, we are not
        prohibited from doing so.  In the event we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from independent investment banking firm or another independent entity that commonly renders valuation
        opinions that such a business combination is fair to our company from a financial point of view;

       

      • If a shareholder vote on our initial business combination is not required by applicable law or stock exchange listing requirements and we do not decide to hold a
        shareholder vote for business or other reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business
        combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act;

       

      • So long as our securities are then listed on Nasdaq, our initial business combination must occur with one or more target businesses that together have an aggregate fair
        market value of at least 80% of the assets held in the trust account (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the
        initial business combination;

       

      • If our shareholders approve an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our
        obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination
        within 24 months from the closing of our initial public offering or during any Extension Period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, we will provide our public shareholders
        with the opportunity to redeem all or a portion of their ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in
        the trust account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to the limitations described herein; and

       

      • We will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations.

       

      In addition, our amended and restated memorandum and articles of association provide that under no circumstances will we redeem our public shares in an
        amount that would cause our net tangible assets to be less than $5,000,001.

       

      The Companies Act permits a company incorporated in the Cayman Islands to amend its memorandum and articles of association with the approval of a
        special resolution.  A company’s articles of association may specify that the approval of a higher majority is required but, provided the approval of the required majority is obtained, any Cayman Islands exempted company may amend its memorandum
        and articles of association regardless of whether its memorandum and articles of association provide otherwise.

       

      Accordingly, although we could amend any of the provisions relating to our proposed offering, structure and business plan which are contained in our
        amended and restated memorandum and articles of association, we view all of these provisions as binding obligations to our shareholders and neither we, nor our officers or directors, will take any action to amend or waive any of these provisions
        unless we provide dissenting public shareholders with the opportunity to redeem their public shares.

       

      
        20

        
          

      

      Anti-Money Laundering, Counter Terrorist Financing, Prevention of Proliferation Financing and Financial Sanctions Compliance—Cayman Islands

       

      If any person resident in the Cayman Islands knows or suspects, or has reasonable grounds for knowing or suspecting, that another person is engaged in criminal conduct,
        is involved with terrorism or terrorist property or proliferation financing or is the business combination partner of a financial sanction and the information for that knowledge or suspicion came to their attention in the course of business in the
        regulated sector or other trade, profession, business or employment, the person will be required to report such knowledge or suspicion to (i) the Financial Reporting Authority of the Cayman Islands, pursuant to the Proceeds of Crime Act (as
        amended) of the Cayman Islands if the disclosure relates to criminal conduct, money laundering or proliferation financing or is the business combination partner of a financial sanction; or (ii) a police officer of the rank of constable or higher,
        or the Financial Reporting Authority, pursuant to the Terrorism Act (as amended) of the Cayman Islands, if the disclosure relates to involvement with terrorism or terrorist financing and property. Such a report will not be treated as a breach of
        confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise. We reserve the right to refuse to make any payment to a shareholder if our directors or officers suspect or are advised that the payment to
        such shareholder might result in a breach of applicable anti-money laundering, counter-terrorist financing, prevention of proliferation financing and financial sanctions or other laws or regulations by any person in any relevant jurisdiction, or if
        such refusal is considered necessary or appropriate to ensure our compliance with any such laws or regulations in any applicable jurisdiction. Certain Anti-takeover Provisions of our Amended and
          Restated Memorandum and Articles of Association

       

      Our amended and restated memorandum and articles of association provides that our board of directors will be classified into three classes of
        directors.  Prior to the completion of our initial business combination, only holders of our founder shares will have the right to vote on the appointment of directors.  Holders of our public shares will not be entitled to vote on the appointment
        of directors during such time.  In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. In addition, in a vote to continue
        the company in a jurisdiction outside the Cayman Islands (including any ancillary votes or approvals required in connection with any such continuation to another jurisdiction including, but not limited to, the approval of the organizational
        documents of the company in such other jurisdiction), which requires the approval of at least two thirds of the votes of all ordinary shares, holders of our founder shares will have ten votes for every founder share and holders of our Class A
        ordinary shares will have one vote for every Class A ordinary share and, as a result, our initial shareholders will be able to approve any such proposal without the vote of any other shareholder.

       

      Our authorized but unissued Class A ordinary shares and preference shares will be available for future issuances without shareholder approval and could
        be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans.  The existence of authorized but unissued and unreserved Class A ordinary shares and preference shares
        could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

       

      Securities Eligible for Future Sale

       

      As of December 31, 2021, there were 23,000,000 Class A ordinary shares issued and outstanding and 5,750,000 Class B ordinary shares issued and
        outstanding.  the Class A ordinary shares are freely tradable without restriction or further registration under the Securities Act, except for any Class A ordinary shares purchased by one of our affiliates within the meaning of Rule 144 under the
        Securities Act.  All of the outstanding founder shares and all of the outstanding private placement warrants are restricted securities under Rule 144, in that they were issued in private transactions not involving a public offering.

       

      Upon the closing of the sale of the forward purchase units, all of the forward purchase shares, forward purchase warrants and Class A ordinary shares
        underlying the forward purchase warrants will be restricted securities under Rule 144.

       

      
        21

        
          

      

      Rule 144

       

      Pursuant to Rule 144, a person who has beneficially owned restricted shares or warrants for at least six months would be entitled to sell their
        securities provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale and (ii) we are subject
        to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the twelve months (or such shorter period as we were required to
        file reports) preceding the sale.

       

      Persons who have beneficially owned restricted shares or warrants for at least six months but who are our affiliates at the time of, or at any time
        during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three- month period only a number of securities that does not exceed the greater of:

       

      • 1% of the total number of ordinary shares then-outstanding, which will equal 230,000 shares; or

       

      • the average weekly reported trading volume of the Class A ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to
        the sale.

       

      Sales by our affiliates under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public
        information about us.

       

      Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies

       

      Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or
        issuers that have been at any time previously a shell company.  However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:

       

      • the issuer of the securities that was formerly a shell company has ceased to be a shell company;

       

      • the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;

       

      • the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding twelve months (or such shorter
        period that the issuer was required tofile such reports and materials), other than Form 8-K reports; and at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an
        entity that is not a shell company.

       

      As a result, our sponsor will be able to sell its founder shares and private placement warrants, as applicable, pursuant to Rule 144 without
        registration one year after we have completed our initial business combination.

       

      Registration and Shareholder Rights

       

      The holders of the founder shares, private placement warrants and any warrants that may be issued upon conversion of working capital loans (and any
        Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans) are entitled to registration rights pursuant to a registration and shareholder rights
        agreement.  The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities.  In addition, the holders have certain “piggy-back” registration rights with respect to
        registration statements filed subsequent to our completion of our initial business combination.  However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act
        to become effective until termination of the applicable lockup period, which occurs (i) in the case of the founder shares, as described in the following paragraph, and (ii) in the case of the private placement warrants and the respective Class A
        ordinary shares underlying such warrants, 30 days after the completion of our initial business combination.  We will bear the expenses incurred in connection with the filing of any such registration statements.

       

      
        22

        
          

      

      Pursuant to the forward purchase agreement, we have agreed that we will use our commercially reasonable efforts to (i) within 30 days after the closing
        of the initial business combination, file a registration statement with the SEC for a secondary offering of (A) the forward purchase investor’s forward purchase shares, (B) the Class A ordinary shares issuable upon exercise of the forward purchase
        investor’s forward purchase warrants and (C) any other Class A ordinary shares acquired by the forward purchase investor, including any acquisitions after we complete our initial business combination, (ii)
        cause such registration statement to be declared effective promptly thereafter, but in no event later than 90 days after the closing of the initial business combination and (iii) maintain the effectiveness of such registration statement and to
        ensure the registration statement does not contain a material omission or misstatement, including by way of amendment or other update, as required, until the earlier of (A) the date on which the forward purchase investor ceases to hold the
        securities covered thereby and (B) the date all of the securities covered thereby can be sold publicly without restriction or limitation under Rule 144 under the Securities Act, and without the requirement to be in compliance with Rule 144(c)(1)
        under the Securities Act, subject to certain conditions and limitations set forth in the forward purchase agreement.  We will bear the cost of registering these securities.

       

      Except as described herein, our sponsor, our directors and executive officers and the forward purchase investor has agreed not to transfer, assign or
        sell their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds
        $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or
        (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property.  Any
        permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares.  We refer to such transfer restrictions throughout this exhibit as the lock-up.

       

      In addition, pursuant to the registration and shareholder rights agreement, our sponsor, upon and following consummation of an initial business
        combination, will be entitled to nominate three individuals for appointment to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement.

       

      

       

      

      
        23Exhibit 10.1

 

PROMISSORY NOTE

 

March 29, 2022

 

$265,750.10   

 

Tuscan Holdings Corp. II (“Maker”)
promises to pay to the order of Tuscan Holdings Acquisition II LLC or its successors or assigns (“Payee”) the principal sum
of Two Hundred Sixty Five Thousand Seven Hundred Fifty One dollars and Ten Cents ($265,750.10) in lawful money of the United States of
America, on the terms and conditions described below.

 

1. Principal. The principal balance
of this Note shall be repayable on the consummation of the Maker’s initial merger, capital stock exchange, asset acquisition or
other similar business combination with one or more businesses or entities (a “Business Combination”). Payee understands that
if a Business Combination is not consummated, this Note will not be repaid and all amounts owed hereunder will be forgiven except to the
extent that the Maker has funds available to it outside of its trust account established in connection with its initial public offering.

 

2. Interest. No interest shall accrue
on the unpaid principal balance of this Note.

 

3. Application of Payments. All payments
shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation)
reasonable attorneys’ fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal
balance of this Note.

 

4. Events of Default. The following
shall constitute Events of Default:

 

(a) Failure to Make Required Payments.
Failure by Maker to pay the principal of this Note within five (5) business days following the date when due.

 

(b) Voluntary Bankruptcy, Etc. The
commencement by Maker of a voluntary case under the Federal Bankruptcy Code, as now constituted or hereafter amended, or any other applicable
federal or state bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment
of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of Maker or
for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker
generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

 

(c) Involuntary Bankruptcy, Etc. The
entry of a decree or order for relief by a court having jurisdiction in the premises in respect of maker in an involuntary case under
the Federal Bankruptcy Code, as now or hereafter constituted, or any other applicable federal or state bankruptcy, insolvency or other
similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any
substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or
order unstayed and in effect for a period of 60 consecutive days.

 

5. Remedies.

 

(a) Upon the occurrence of an Event of Default
specified in Section 4(a), Payee may, by written notice to Maker, declare this Note to be due and payable, whereupon the principal amount
of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest
or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same
to the contrary notwithstanding.

 

(b) Upon the occurrence of an Event of Default
specified in Sections 4(b) and 4(c), the unpaid principal balance of, and all other sums payable with regard to, this Note shall automatically
and immediately become due and payable, in all cases without any action on the part of Payee.

 

     

     

    

 

6. Intentionally Omitted.

 

7. Waivers. Maker and all endorsers
and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest
with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and
all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part
of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of
execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon
pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in
part in any order desired by Payee.

 

8. Unconditional Liability. Maker hereby
waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and
agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any
manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and
all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions
of this Note, and agree that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to them or
affecting their liability hereunder.

 

9. Notices. Any notice called for hereunder
shall be deemed properly given if (i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched by
any form of private or governmental express mail or delivery service providing receipted delivery, (iv) sent by telefacsimile or (v) sent
by e-mail, to the following addresses or to such other address as either party may designate by notice in accordance with this Section:

 

If to Maker:

 

Tuscan Holdings Corp. II

135 E. 57th Street, 17th Floor

New York, New York 10022

 

If to Payee:

 

Tuscan Holdings Acquisition II LLC

135 E. 57th Street, 17th Floor

New York, New York 10022

 

Notice shall be deemed given on the earlier of (i) actual receipt by
the receiving party, (ii) the date shown on a telefacsimile transmission confirmation, (iii) the date on which an e-mail transmission
was received by the receiving party’s on-line access provider (iv) the date reflected on a signed delivery receipt, or (vi) two
(2) Business Days following tender of delivery or dispatch by express mail or delivery service.

 

10. Construction. This Note shall be
construed and enforced in accordance with the domestic, internal law, but not the law of conflict of laws, of the State of New York.

 

11. Severability. Any provision contained
in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of
such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

    2

     

    

 

IN WITNESS WHEREOF, Maker, intending to be legally
bound hereby, has caused this Note to be duly executed the day and year first above written.

 

	 	TUSCAN HOLDINGS CORP. II
	 	 	 
	 	By:	/s/ Stephen Vogel
	 	Name: 	Stephen Vogel
	 	Title:	Chief Executive Officer

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]